New York Oncology Hematology (NYOH) — Amsterdam, New York

New York Oncology Hematology (NYOH) is a clinical research site located in Amsterdam, New York, United States 12010.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology (NYOH) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology (NYOH)?

New York Oncology Hematology (NYOH) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology (NYOH) conducted?

New York Oncology Hematology (NYOH) has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer.

Is New York Oncology Hematology (NYOH) accredited by Crixeo Health?

New York Oncology Hematology (NYOH) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology (NYOH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.